The EECP treatment system consists of three main components:
- Adjustable cuffs that wrap around the patient’s calves, thighs, and buttocks
- An electrocardiogram (ECG) to monitor heart rhythm
- A computerized control system that synchronizes cuff inflation and deflation with the patient’s cardiac cycle
How does EECP therapy work?
The mechanism behind EECP treatment involves carefully timed counterpulsation that works in harmony with the heart’s natural rhythm. During EECP treatment:
- Diastole Phase: When the heart is at rest (diastole), the cuffs rapidly inflate sequentially from the calves upward, creating a wave-like compression that propels blood back toward the heart. This retrograde pressure during EECP treatment increases coronary perfusion pressure and blood flow to the myocardium.
- Systole Phase: Just before the heart contracts (systole), the cuffs rapidly deflate simultaneously, reducing the resistance the heart must pump against. This “systolic unloading” during EECP treatment decreases the heart’s workload and oxygen demand.
This precisely timed sequence in EECP treatment creates several beneficial hemodynamic effects:
- Increased coronary blood flow
- Enhanced venous return to the heart
- Reduced cardiac workload
- Improved oxygen supply to the heart muscle
Mechanism of Action
EECP treatment works through multiple physiological pathways that collectively improve cardiovascular function:
Hemodynamic Effects of EECP Treatment
The immediate hemodynamic benefits of EECP treatment include:
- Increased diastolic pressure, improving coronary perfusion by 20-40%
- Decreased systolic pressure, reducing cardiac afterload
- Improved cardiac output and stroke volume
- Enhanced venous return
Vascular Effects during EECP Treatment
EECP treatment generates significant changes in the vascular system:
Development of New Blood Vessels
EECP treatment stimulates angiogenesis (formation of new blood vessels) through:
- Increased shear stress on vessel walls
- Upregulation of vascular endothelial growth factor (VEGF)
- Activation of the hypoxia-inducible factor 1-alpha (HIF-1α) pathway
- Release of stem cell mobilizing factors
These processes during EECP treatment lead to the formation of new capillary networks that improve blood flow to oxygen-deprived tissues.
Dilation of Existing Blood Vessels
EECP treatment enhances vasodilation through:
- Increased nitric oxide (NO) production
- Improved endothelial function
- Reduced endothelin-1 levels (a potent vasoconstrictor)
- Decreased sympathetic nervous system activity
Cellular and Molecular Mechanisms
At the cellular level, EECP treatment triggers:
- Increased production of endothelial progenitor cells
- Reduced inflammation markers (C-reactive protein, tumor necrosis factor-alpha)
- Improved peripheral vascular resistance
- Enhanced oxygen utilization at the tissue level
What conditions can EECP therapy treat?
EECP treatment has been approved for and shown efficacy in treating numerous cardiovascular and related conditions:
Primary Applications of EECP Treatment
- Chest pain (Angina): EECP treatment is FDA-approved for chronic, stable angina that doesn’t respond adequately to medication or isn’t suitable for invasive procedures.
- Coronary artery disease: EECP treatment improves blood flow in patients with significant coronary blockages.
- Shortness of breath (dyspnea): Many patients report improved breathing capacity after EECP treatment.
- Fatigue: EECP treatment can increase energy levels by improving overall circulatory function.
- Cough: Some patients with cardiac-related cough experience symptom relief after EECP treatment.
Other Conditions Benefiting from EECP Treatment
EECP treatment has shown promising results for:
- Cardiac syndrome X: EECP treatment improves microvascular function in patients with angina but normal coronary arteries.
- Heart failure: EECP treatment enhances cardiac function and exercise capacity in heart failure patients.
- Left ventricular dysfunction: EECP treatment can improve ejection fraction and cardiac performance.
- Cerebrovascular disease: EECP treatment may enhance cerebral circulation and cognitive function.
- Kidney (renal) failure: EECP treatment can improve renal perfusion and potentially slow disease progression.
- Peripheral artery disease (PAD): EECP treatment increases collateral circulation in the extremities.
- Erectile dysfunction: By improving vascular function, EECP treatment may benefit men with vascular-related erectile dysfunction.
- Lung disease: Some patients with pulmonary hypertension show improvement with EECP treatment.
- Diabetes: EECP treatment may improve peripheral circulation and reduce diabetes-related complications.
Who is eligible for EECP therapy?
Ideal candidates for EECP treatment include:
- Patients with chronic, stable angina who have exhausted medication options
- Individuals who are not candidates for bypass surgery or angioplasty
- Patients seeking non-invasive alternatives to surgical interventions
- Those with persistent symptoms despite prior revascularisation procedures
- Patients with multiple risk factors who want to improve their cardiovascular health
Before starting EECP treatment, patients undergo a comprehensive evaluation including:
- Complete medical history
- Physical examination
- Cardiovascular assessments
- Evaluation of symptom severity and frequency
Who Should Not Undergo EECP Treatment?
EECP treatment is contraindicated or requires special consideration in patients with:
- Severe Aortic insufficiency: The increased diastolic pressure from EECP treatment may worsen this condition.
- Atrial fibrillation (Afib): Irregular heartbeats can interfere with proper EECP treatment timing.
- Blood clots: EECP treatment may dislodge existing clots.
- Congenital heart disease: Certain structural abnormalities may complicate EECP treatment.
- Sever Enlarged heart (cardiomegaly): May affect EECP treatment effectiveness.
- Heart valve disease: Especially severe mitral or aortic regurgitation.
- Hemorrhage: Active bleeding is a contraindication for EECP treatment.
- Severe hypertension: Uncontrolled high blood pressure must be managed before EECP treatment.
- Irregular heartbeat or fast heart rate (tachycardia): These can interfere with EECP treatment synchronization.
- Hypertrophic cardiomyopathy: The altered hemodynamics may be problematic.
- Pulmonary hypertension (PH): Severe cases require careful evaluation before EECP treatment.
- Severe peripheral vascular disease: May limit the effectiveness of EECP treatment.
- Recent cardiac catheterization: Typically requires a waiting period before EECP treatment.
- Pregnancy: EECP treatment has not been studied in pregnant women.
- Deep vein thrombosis: Increases risk of complications during EECP treatment.
Is EECP therapy a common procedure?
While EECP treatment has been FDA-approved since 1995 and has gained recognition worldwide, it isn’t as widely available as some conventional cardiac procedures. The popularity of EECP treatment varies by region:
- In the United States, over 1,200 centers offer EECP treatment
- EECP treatment has received approval from regulatory bodies in Europe, Asia, and Australia
- The International EECP Patient Registry has documented outcomes for over 30,000 patients who have undergone EECP treatment
- More than 20,000 EECP treatment procedures are performed annually in the US alone
Despite its proven benefits, EECP treatment remains underutilized partly due to:
- Limited awareness among both patients and healthcare providers
- Insurance coverage variations
- The substantial time commitment required for the full EECP treatment course
International Approvals for EECP Treatment
EECP treatment has received regulatory approval from numerous health authorities worldwide:
- FDA approval in the United States (1995)
- CE Mark in Europe
- PMDA approval in Japan
- TGA approval in Australia
- CDSCO approval in India
- NMPA (formerly CFDA) approval in China
These approvals reflect the growing body of evidence supporting EECP treatment’s safety and efficacy, with international clinical guidelines increasingly recognizing EECP treatment as an important therapeutic option for selected patients.
The EECP Treatment Experience
What happens before EECP therapy?
Preparation for EECP treatment involves:
- Initial consultation: A specialist evaluates the patient’s medical history, current symptoms, and treatment goals for EECP treatment.
- Baseline assessments: Before starting EECP treatment, measurements typically include:
- Blood pressure and heart rate
- Electrocardiogram (ECG)
- Exercise capacity evaluation
- Quality of life questionnaires
- Blood tests to assess cardiac biomarkers
- Education: Patients receive detailed information about the EECP treatment process, expected outcomes, and timeline.
- Clothing guidance: Patients are advised to wear comfortable, loose-fitting clothing to EECP treatment sessions.
What happens during EECP therapy?
A typical EECP treatment session follows this sequence:
- The patient lies comfortably on a treatment table.
- Three sets of pressure cuffs are wrapped around the calves, lower thighs, and upper thighs/buttocks.
- ECG electrodes are placed to monitor heart rhythm and synchronize the EECP treatment system.
- A finger plethysmograph monitors blood pressure waves during EECP treatment.
- The computer-controlled system inflates and deflates the cuffs in precise timing with the cardiac cycle.
- During EECP treatment, patients can read, watch television, or even nap.
- Medical staff regularly check the patient’s comfort and vital signs throughout the EECP treatment session.
Many patients report that EECP treatment feels like a strong massage of the legs and buttocks, with a squeezing sensation moving up the legs during each heartbeat.
How long does EECP therapy last?
The standard EECP treatment protocol consists of:
- 35 one-hour sessions
- Usually scheduled 5 days per week
- The full course typically takes 7 weeks to complete
- Each EECP treatment session includes a few minutes for setup and removal of the cuffs
Some variations in EECP treatment scheduling may occur based on individual needs:
- Extended protocols (up to 50 sessions) for severe conditions
- Compressed schedules (twice daily sessions) for patients traveling from distant locations
- Maintenance EECP treatment sessions (monthly or quarterly) for some patients after completing the initial course
The commitment to a full EECP treatment course is crucial for optimal results, as the beneficial effects of EECP treatment are cumulative.
Read Also: EECP Treatment for Chest Pain
Recovery and Outlook
Patient Experience after EECP therapy
Patient experiences during and after EECP treatment vary:
- During early sessions: Some patients may experience fatigue after EECP treatment as their body adjusts to the therapy.
- Mid-course: Many begin noticing improvements in symptoms by the 15-20th EECP treatment session.
- Upon completion: Most patients report significant improvement in:
- Exercise capacity
- Reduction in angina episodes
- Decreased need for nitroglycerin
- Improved quality of life
- Enhanced energy levels
Recovery time from EECP
One of the significant advantages of EECP treatment is the minimal recovery time:
- No downtime between sessions
- Patients can return to normal activities immediately after each EECP treatment
- No hospitalization required
- No wound care or activity restrictions
- Patients can drive themselves to and from EECP treatment appointments
This makes EECP treatment particularly suitable for:
- Elderly patients
- Those with multiple comorbidities
- Individuals who cannot afford extended time away from work or family responsibilities
Can I have EECP therapy more than once?
Many patients benefit from repeat courses of EECP treatment:
- Initial benefits of EECP treatment typically last 3-5 years for most patients
- When symptoms begin to return, a repeat course of EECP treatment is often beneficial
- Some patients receive a “booster” course of 15-20 EECP treatment sessions at regular intervals
- Maintenance protocols may involve periodic single EECP treatment sessions to sustain benefits
There is no limit to the number of EECP treatment courses a patient can receive over their lifetime, provided they remain appropriate candidates.
Risks and Benefits
What are the advantages of EECP therapy?
EECP treatment offers numerous benefits:
- Non-invasive: EECP treatment requires no incisions, anesthesia, or radiation exposure.
- Outpatient procedure: EECP treatment requires no hospitalization.
- Cumulative benefits: The effects of EECP treatment continue to improve over the course of therapy.
- Sustained results: Benefits often last 3-5 years after a course of EECP treatment.
- Improved exercise capacity: Most patients show significant functional improvement after EECP treatment.
- Reduced medication needs: Many patients require fewer anti-anginal medications after EECP treatment.
- Fewer angina episodes: The frequency and intensity of chest pain typically decrease with EECP treatment.
- Enhanced quality of life: Patients report better daily functioning after EECP treatment.
- Safe for multiple courses: EECP treatment can be repeated when symptoms return.
- Complementary therapy: EECP treatment works well alongside conventional treatments.
What are the risks or complications of EECP therapy?
EECP treatment is generally very safe, with minimal risks:
- Skin irritation or bruising: The most common side effect of EECP treatment, occurring in about 5-10% of patients.
- Edema: Mild swelling in the legs may occur during the EECP treatment course but typically resolves quickly.
- Fatigue: Some patients experience temporary tiredness after initial EECP treatment sessions.
- Muscle or joint discomfort: Minor aches may occur as the body adjusts to EECP treatment.
- Numbness or tingling: Occasionally reported during EECP treatment sessions but resolves when pressure is released.
- Pressure sores: Rare with modern EECP treatment equipment and proper technique.
Serious complications from EECP treatment are extremely rare, with studies reporting rates below 0.5%.
Conclusion
EECP treatment represents a significant advancement in non-invasive cardiovascular therapy, offering hope to patients who have limited options or have not responded adequately to conventional treatments. This FDA-approved therapy leverages the body’s natural circulatory mechanics to improve blood flow, stimulate new vessel formation, and enhance overall cardiovascular function.
For patients with angina, heart failure, and various other cardiovascular conditions, EECP treatment provides a safe, effective option with minimal risks and substantial potential benefits. As awareness grows and more research emerges, EECP treatment is likely to become an increasingly important component of comprehensive cardiovascular care.
If you or someone you know suffers from chronic angina or other cardiovascular symptoms that haven’t responded adequately to standard treatments, consider discussing EECP treatment with a healthcare provider to determine if this therapy might be appropriate.
About Vivek Sengar
Vivek Sengar is the founder of Fit My Heart and a leading expert in Non-Invasive and Preventive Cardiology. With over 11 years of clinical experience, he has helped thousands of patients avoid bypass surgery and stents through EECP Therapy, lifestyle changes, and natural heart care protocols. His mission is to make heart treatment safer, more effective, and surgery-free using globally accepted, evidence-based techniques.
Founder of Fit My Heart | Expert in Non-Surgical Heart Care
Get a Second Opinion on Chest Pain or Blockages Know if EECP is Right for You
Frequently Asked Questions About EECP Treatment
Q: What does EECP stand for?
A: EECP stands for Enhanced External Counterpulsation, a non-invasive treatment for certain cardiovascular conditions.
Q: How does EECP therapy work?
A: EECP uses inflatable cuffs on the legs that synchronize with your heartbeat to improve blood flow to the heart by compressing during the heart’s resting phase.
Q: What conditions can EECP treat?
A: EECP primarily treats angina, coronary artery disease, heart failure, and can help patients who aren’t candidates for surgery or other interventions.
Q: How long is a typical EECP session?
A: Each EECP session typically lasts 1 hour, with patients usually receiving 35 sessions over a 7-week period.
Q: Is EECP therapy painful?
A: EECP is not painful, though some patients report a tight squeezing sensation. Most find it comfortable enough to read or nap during treatment.
Q: How soon can patients expect results from EECP?
A: Some patients notice improvement after 15-20 sessions, though maximum benefits are typically observed after completing the full course of treatment.
Q: How long do the benefits of EECP last?
A: Benefits typically last 2-5 years for most patients, with some experiencing relief for even longer periods.
Q: Who is not eligible for EECP treatment?
A: EECP is not recommended for patients with severe aortic insufficiency, recent cardiac catheterization, irregular heartbeats, or blood clotting issues.
Q: Does insurance cover EECP therapy?
A: In USA Many insurance plans, including Medicare, cover EECP therapy for patients with refractory angina who meet specific criteria, but in India getting the insurance cover is not easy but if there are no other option and your doctor is strongly recommonding you for EECP then some insurance companies may give the coverage under special health conditions.
Q: Can EECP replace bypass surgery or angioplasty?
A: It’s a Subjective question. In many cases, it can avoid the need for Bypass surgery, but EECP is not a replacement for these procedures, but serves as an alternative for patients who cannot undergo them or as complementary therapy.
Q: What side effects might occur with EECP?
A: Minor side effects may include skin irritation, muscle fatigue, or slight bruising. Serious side effects are extremely rare.
Q: Can I continue taking my medications during EECP treatment?
A: Yes, patients should continue their prescribed medications during EECP therapy unless directed otherwise by their physician.
Q: Is there any special preparation needed before an EECP session?
A: Wear comfortable, loose-fitting clothing, avoid heavy meals before treatment, and ensure proper hydration for optimal results.
Q: How is EECP different from a blood pressure cuff?
A: While both use compression, EECP uses multiple cuffs precisely synchronized with the heart cycle and delivers much stronger, sequential pressure.
Q: Can I resume normal activities after EECP therapy?
A: Yes, most patients can immediately resume normal daily activities, with many reporting increased energy and exercise capacity after completing treatment.